<<
Page 1
>>
|
HEART & VESSEL - STROKE, HEART, AND VASCULAR WELLNESS NEWS
|
12/05/12 -
Treating gum disease may treat erectile dysfunction
By Joseph Brownstein
Published December 04, 2012
MyHealthNewsDaily
Read more: http://www.foxnews.com/health/2012/12/04/treating-gum-disease-may-treat-erectile-dysfunction/#ixzz2EEikL0gh
More
|
11/22/12 -
Repairing chronic myocardial infarction with autologous mesenchymal stem cells engineered tissue in rat promotes angiogenesis and limits ventricular remodeling
More
|
11/22/12 - Losing Job Ups Heart Attack Risk
By John Gever, Senior Editor, MedPage Today
Published: November 19, 2012
Reviewed by Zalman S. Agus, MD; Emeritus Professor, Perelman School of Medicine at the University of Pennsylvania and Dorothy Caputo, MA, BSN, RN, Nurse Planner
More
|
05/04/10 -
Type 2 Diabetes and TCF7L2 - Author: Ali Torkamani, PhD, Assistant Faculty, Research, Scripps Genomic Medicine and Assistant Professor of Molecular and Experimental Medicine, Scripps Research Institute
TCF7L2 variants have been associated with type 2 diabetes in multiple ethnic groups.1,2,3,4,5,6,7 Specific associated variants increase risk of type 2 diabetes 1.5-fold in heterozygotes and 2.41-fold in homozygotes, corresponding to a population attributable risk of 21%. This makes TCF7L2 variants the strongest known genetic risk factor for type 2 diabetes.8
TCF7L2 is a transcription factor and key component of the Wnt signaling pathway, and is involved in the development of a wide variety of cell lineages and organs.9 Potential mechanisms by which TCF7L2 variants influence type 2 diabetes include its role in adipogenesis, myogenesis, and pancreatic islet development, as well transcription of the genes for proglucagon and the glucagon-like-peptides GLP-1 and GLP-2, which play a role in post-prandial insulin secretion.10 Additionally, TCF7L2 polymorphisms have been associated with impaired insulin secretion, glucose production, and glucose tolerance via direct effects on pancreatic islet beta-cells.11,12 Thus, while the specific mechanism driving the development of type 2 diabetes remains unclear, there is sufficient evidence to demonstrate that TCF7L2 variants strongly predict the development of type 2 diabetes and/or the progression to diabetes from impaired glucose tolerance.12,13
More
|
04/23/10 - Heart drugs may be as effective as angioplasty - Hundreds of people with angina may be unnecessarily undergoing angioplasty -- a common procedure to clear clogged coronary arteries that carries a small but real risk of heart attack and stroke -- because drugs alone work just as well, Canadian researchers are reporting.
More
|
04/22/10 - EXA Test : healthcare professionals perform a MAGNESIUM CALCIUM POTASSIUM PHOSPHORUS SODIUM CHLORIDE
More
|
06/09/09 - Vegetarian Atkins diet lowers heart risks - study -- CHICAGO, June 8 (Reuters) - A vegetarian version of the Atkins low-carb diet may help people lose weight and lower levels of bad cholesterol in the blood, Canadian researchers said on Monday. A small, month-long study of the so-called Eco-Atkins diet, which stresses plant proteins, worked better than a high-carb diet at reducing levels of low-density lipoprotein or LDL, which raises the risks of heart attacks and strokes.
More
|
05/28/09 - Stroke Treatment Window Widens -- Immediate Treatment Best, but Even Late Treatment With tPA May Help -- By Daniel J. DeNoon -- Reviewed by Louise Chang, MD -- May 28, 2009 -- After a stroke, you've got very little time to get treatment. But some patients now have a bit more time. A stroke occurs when a clot cuts off blood flow to parts of the brain. Those parts of the brain soon start to die. A drug called tissue plasminogen activator -- tPA -- dissolves clots and restores blood flow.
More
|
<<
Page 1
>>
|
